TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bioteria Technologies AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
136,100
|
106,282
|
95,253 |
| Financial expenses |
2,205
|
1,365
|
173 |
| Earnings before taxes |
-15,375
|
-9,088
|
3,741 |
| EBITDA |
-5,155
|
-843
|
8,721 |
| Total assets |
95,277
|
92,903
|
52,664 |
| Current assets |
39,389
|
35,409
|
40,306 |
| Current liabilities |
58,008
|
64,417
|
29,735 |
| Equity capital |
7,812
|
11,386
|
21,337 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
60
|
63
|
56 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
8.2%
|
12.3%
|
40.5% |
| Turnover per employee |
2,268
|
1,687
|
1,701 |
| Profit as a percentage of turnover |
-11.3%
|
-8.6%
|
3.9% |
| Return on assets (ROA) |
-13.8%
|
-8.3%
|
7.4% |
| Current ratio |
67.9%
|
55.0%
|
135.6% |
| Return on equity (ROE) |
-196.8%
|
-79.8%
|
17.5% |
| Change turnover |
29,818
|
11,029
|
14,974 |
| Change turnover % |
28%
|
12%
|
19% |
| Chg. No. of employees |
-3
|
7
|
15 |
| Chg. No. of employees % |
-5%
|
13%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.